Magical words in SSB's report - "waiting for final closure before buying the stock will probably prove too late, as the price will invariably gap-up."SSB have upgraded Nylex to Buy and increased target price from 44 cents to 54 cents.
NTI Neurotech knocked back by FDA as agency declares target condition not rare enough for special status